Fibrosis Diagnosis Takes a New Turn
BioSpectrum Asia speaks to Dr Gideon Ho, CEO of Histoindex, which aims to bring a revolutionary platform into the global tissue diagnostics market for the detection and quantification of fibrosis.
BioSpectrum Asia speaks to Dr Gideon Ho, CEO of Histoindex, which aims to bring a revolutionary platform into the global tissue diagnostics market for the detection and quantification of fibrosis.
HistoIndex sets new standards in fibrosis diagnosis and is recognised as an industry-leading emerging company in 2012!